Published in Immunol Today on May 01, 1990
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med (1994) 2.33
Human anti-self antibodies with high specificity from phage display libraries. EMBO J (1993) 2.08
IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest (1996) 1.34
Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest (1994) 1.16
Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol (1991) 1.08
Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann Rheum Dis (1992) 1.04
Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis (1991) 1.00
High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. J Clin Invest (1995) 0.97
Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Invest (1993) 0.94
Selective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibody. Br J Cancer (1992) 0.89
Active immunization by a dengue virus-induced cytokine. Clin Exp Immunol (1994) 0.82
An expanding role for interleukin-1 blockade from gout to cancer. Mol Med (2014) 0.82
Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-alpha in normal human sera. Clin Exp Immunol (1992) 0.82
Induction of cytokines and anti-cytokine autoantibodies in cerebrospinal fluid (CSF) during experimental bacterial meningitis. Clin Exp Immunol (1998) 0.78
Constitutive, but not challenge-induced, interleukin-10 production is robust in acute pre-pubescent protein and energy deficits: new support for the tolerance hypothesis of malnutrition-associated immune depression based on cytokine production in vivo. Int J Environ Res Public Health (2011) 0.77
Autoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens. J Immunol (2014) 0.77
Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL. PLoS One (2014) 0.76
Cytokines and autoimmunity. Clin Exp Immunol (1994) 0.76
Levels of gamma interferon and interleukin-4 are inversely related to the levels of their corresponding autoantibodies in patients with lower respiratory tract infection. Infect Immun (1999) 0.75
Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma. MAbs (2014) 0.75
Effect of adjuvants on immunization with dengue virus-induced cytotoxic factor. Clin Exp Immunol (1995) 0.75
Depression of chemiluminescence during dengue virus infection of mice: role of cytokines. Int J Exp Pathol (1993) 0.75
Cytokines as cellular communicators. Mediators Inflamm (1996) 0.75
What is the function of autoantibodies to cytokines? Immunol Today (1990) 0.75
A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies. PLoS One (2016) 0.75
Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity. Infect Immun (1993) 0.75
Serum levels of interleukin-6 are not dependent on the kidney function. Mediators Inflamm (1992) 0.75
Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science (1986) 2.83
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. Ann Rheum Dis (2008) 2.21
Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol (2000) 2.15
Severe and common side-effects of amphotericin B lipid complex (Abelcet) Bone Marrow Transplant (1998) 2.05
Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2011) 1.70
Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group. Eur J Haematol (1994) 1.56
Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. Pediatr Pulmonol (1993) 1.51
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist. Nat Biotechnol (1997) 1.47
Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG) Br J Haematol (1991) 1.45
A new homeobox-leucine zipper gene from Arabidopsis thaliana. Plant Mol Biol (1992) 1.44
Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia (1986) 1.42
[Pernicious anemia. A study of initial forms of the disease and diagnostic significance of determination of the intrinsic factor antibody and parietal cell antibody]. Ugeskr Laeger (1992) 1.38
Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol (1988) 1.37
Effect of cyclosporin A on human neutrophil and monocyte function. Scand J Immunol (1985) 1.35
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer (2007) 1.33
Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand J Immunol (1989) 1.23
Leiomyosarcoma of the urinary bladder after cyclophosphamide. J Clin Oncol (1995) 1.18
Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis (1994) 1.16
Nature of vitamin B 12 binding. 3. Thermodynamics of binding to human intrinsic factor and transcobalamins. Biochim Biophys Acta (1971) 1.16
MADS-box genes active in developing pollen cones of Norway spruce (Picea abies) are homologous to the B-class floral homeotic genes in angiosperms. Dev Genet (1999) 1.15
Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group. Ann Neurol (2000) 1.14
Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids. Cell Immunol (1982) 1.13
High-avidity autoantibodies to cytokines. Immunol Today (1998) 1.12
Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol (1996) 1.09
Conservation of gene structure and activity in the regulation of reproductive organ development of conifers and angiosperms. Plant J (1998) 1.09
Vitamin B12 absorption evaluated by a dual isotope test (Dicopac). Results of radioactivity measurements in plasma and in urine. Scand J Haematol (1974) 1.07
[Daily single-dose aminoglycoside administration. Therapeutic and economic benefits]. Ugeskr Laeger (1993) 1.06
Proliferation induced by Plasmodium falciparum antigen and interleukin-2 production by lymphocytes isolated from malaria-immune individuals. Infect Immun (1986) 1.02
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol (2001) 1.01
Anti-interleukin-6 antibodies in normal human serum. Scand J Immunol (1991) 1.00
Chlorambucil treatment of patients with cold agglutinin syndrome. Blood (1970) 0.98
Hereditary factors in pernicious anaemia and their relation to serum-immunoglobulin levels and age at diagnosis. Lancet (1969) 0.98
High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. J Clin Invest (1995) 0.97
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Br J Haematol (1999) 0.96
Human anti-interleukin 1 alpha antibodies. Immunol Lett (1991) 0.94
Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome. Ann Rheum Dis (2002) 0.94
Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases. Infect Immun (1988) 0.94
A homeobox gene with potential developmental control function in the meristem of the conifer Picea abies. Proc Natl Acad Sci U S A (1998) 0.93
Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130. FEBS Lett (1997) 0.93
Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis (1996) 0.92
Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells. Allergy (1985) 0.90
Sex- and age-dependency of IgG auto-antibodies against IL-1 alpha in healthy humans. Eur J Clin Invest (1994) 0.90
High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. Cytokine (1993) 0.90
Nature of vitamin B 12 binding. II. Steric orientation of vitamin B 12 on binding and number of combining sites of human intrinsic factor and the transcobalamins. Biochim Biophys Acta (1971) 0.90
Massive parallel gene expression profiling of RINm5F pancreatic islet beta-cells stimulated with interleukin-1beta. APMIS (2000) 0.89
1 alpha,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro. Immunol Lett (1988) 0.88
TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis. Clin Exp Rheumatol (2004) 0.87
Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand J Infect Dis (1994) 0.87
Antibody to transcobalamin II and B12 binding capacity in patients treated with hydroxocobalamin. Blood (1971) 0.87
Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity (1991) 0.87
Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol (1995) 0.86
Inhibition of rBet v 1-induced basophil histamine release with specific immunotherapy -induced serum immunoglobulin G: no evidence that FcgammaRIIB signalling is important. Clin Exp Allergy (2006) 0.86
Inhibition of human lymphocyte proliferative response by serum from Plasmodium falciparum infected patients. Acta Pathol Microbiol Immunol Scand C (1987) 0.86
Changes in Stokes radius on binding of vitamin B12 to human intrinsic factor and transcobalamins. Biochim Biophys Acta (1970) 0.85
Expression patterns of novel genes encoding homeodomain leucine-zipper proteins in Arabidopsis thaliana. Plant Mol Biol (1994) 0.84
False low serum vitamin B12 values with radiodilution assays using blocked R-binders. Lancet (1983) 0.84
Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy. Blood (1997) 0.84
51Cr labelling of normal human T and B lymphocytes for kinetic studies in vivo. Fundamental lymphocyte kinetic considerations. Scand J Haematol (1978) 0.84
Determination of cobalamins in biological material. II. The cobalamins in human plasma and erythrocytes after desalting on nonpolar adsorbent material, and separation by one-dimensional thin-layer chromatography. Anal Biochem (1983) 0.84
Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma. Oncology (1993) 0.83
[Pseudolymphoma and ventricular maltoma in patients with chronic gastritis, ulcer and Helicobacter pylori infection]. Ugeskr Laeger (2000) 0.83
Cytokine autoantibodies in rheumatoid arthritis. Scand J Rheumatol (1995) 0.83
Traffic of T and B lymphocytes in the normal spleen. Scand J Haematol (1978) 0.83
Familial elevation of serum thyroxine-binding globulin capacity. Acta Endocrinol (Copenh) (1969) 0.83
Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-alpha in normal human sera. Clin Exp Immunol (1992) 0.82
Vitamin B12 absorption determined with a double isotope technique employing incomplete stool collection. Reliability and validity in pernicious anemia. Acta Med Scand (1977) 0.82
Cytokines and autoantibodies to cytokines. Stem Cells (1995) 0.82
Interleukin-6 autoantibodies: possible biological and clinical significance. Leukemia (1995) 0.82
Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system. Clin Exp Immunol (1999) 0.82
Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE. Autoimmunity (1999) 0.82
Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors. J Immunol Methods (1994) 0.81
Cobalamin and cobalamin-binding proteins in plasma related to the clinical condition in chronic myelogenous leukemia. Leukemia (1995) 0.81
Rothia dentocariosa septicaemia in a patient with chronic lymphocytic leukaemia and toxic granulocytopenia. Dan Med Bull (1987) 0.81
Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment. J Endocrinol Invest (1995) 0.81
Increased concentration of transcobalamin I in a patient with metastatic carcinoma of the breast. Scand J Haematol (1978) 0.81
Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group. Lymphokine Res (1989) 0.80
[Determination of vitamin B12 (cobalamine) absorption by means of a simple double-isotope technic. An alternative to Schilling's test]. Ugeskr Laeger (1986) 0.79
Oral contraceptives and the cobalamin (vitamin B12) metabolism. Acta Obstet Gynecol Scand (1985) 0.79
Cobalamin absorption determined by the stool spot test. Reliability in patients with uremia or disorders of the ileum. Scand J Gastroenterol (1986) 0.79
Reversible dementia and neuropathy associated with folate deficiency 16 years after partial gastrectomy. Scand J Haematol (1980) 0.79
Is immunotherapy-induced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity? Int Arch Allergy Immunol (2005) 0.79
Immunoglobulin deposits in peripheral nerve endings detected by skin biopsy in patients with IgM M proteins and neuropathy. Neurology (1987) 0.79
Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient. Chest (1995) 0.79
Cobalamin forms in plasma and tissue during treatment of vitamin B12 deficiency. Scand J Haematol (1982) 0.79
Subcutaneous lesions and bacteraemia due to Stenotrophomonas maltophilia in three leukaemic patients with neutropenia. Br J Dermatol (1997) 0.79
Biological assays for interleukin 1 detection. Comparison of human T lymphocyte, murine thymocyte and NOB-1 assays. Allergy (1991) 0.79
Detection of autoantibodies to cytokines. Mol Biotechnol (2000) 0.79
Studies on the B lymphoblast antigen No. 1 (BB-1) on a series of Burkitt lymphoma lines differing in the expression of the EBV/C3 receptor complex. J Immunol (1983) 0.79
Red blood cell membrane-bound IgG: demonstration of antibodies in patients with autoimmune haemolytic anaemia and immune complexes in patients with rheumatic diseases. Clin Lab Haematol (1984) 0.78
Measurement of human IL-1 by LIF induction, pancreatic islet-cell cytotoxicity, and bone resorption. Lymphokine Res (1986) 0.78
Autoimmunity related to IgM monoclonal gammopathy of undetermined significance. Peripheral neuropathy and connective tissue sensibilization caused by IgM M-proteins. Acta Med Scand (1988) 0.78
Malabsorption of vitamin B12. Report of a case in a 1-year-old boy, including studies of the absorption of B12. Acta Paediatr Scand (1966) 0.78
Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors. Leuk Res (1996) 0.78
Immunization against platelet glycoprotein IIb-IIIa in Glanzmann's thrombasthenia. Eur J Haematol (1997) 0.78
Plasma cobalamin and transcobalamin in patients with primary carcinoma of the liver. A study from Thailand. Scand J Gastroenterol (1983) 0.78
Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors. Eur J Immunol (1995) 0.78
Transcobalamin II as an indicator of activity in metastatic renal adenocarcinoma. Cancer (1983) 0.78